Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study
Nobuya Inagaki, Hubert S Chou, Shuji Tsukiyama, Takuo Washio, Kazuhito Shiosakai, Yasuhiko Nakatsuka, Takashi Taguchi
BMJ Open Diabetes Research and Care Sep 2017, 5 (1) e000424; DOI: 10.1136/bmjdrc-2017-000424